Cover Image
Market Research Report

Generics Global Industry Almanac 2013-2022

Published by MarketLine Product code 353039
Published Content info 459 Pages
Delivery time: 1-2 business days
Price
Back to Top
Generics Global Industry Almanac 2013-2022
Published: October 24, 2018 Content info: 459 Pages
Description

Summary

Global Generics industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2013-17, and forecast to 2022). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Questions Answered:

What was the size of the global generics market by value in 2017?

What will be the size of the global generics market in 2022?

What factors are affecting the strength of competition in the global generics market?

How has the market performed over the last five years?

How large is the global generics market in relation to its regional counterparts?

Scope

  • Essential resource for top-line data and analysis covering the global generics market. Includes market size data, textual and graphical analysis of market growth trends and leading companies.
  • For the purposes of this profile, a generic drug is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generics and all branded generics are included. However, off-patent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the 'generic-eligible' market, are not included.
  • The market value is evaluated at ex-factory prices.
  • Market volume is quantified here as the percentage of the total ethical pharmaceutical market volume in a country or region which is accounted for by generic drugs. It is therefore a generics penetration rate measure, not an absolute measure of market volume.
  • Regional volumes are calculated as weighted averages of countries which make up the region in question where volume data exists.
  • Note that any volumes of "1" (one) or 100% are due to rounding as MarketLine does not believe that generics will ever fully represent 100% of the medicinal market in any country or region.
  • All currency conversions were calculated at constant average annual 2017 exchange rates.
  • The global generics market had total revenues of $307.6bn in 2017, representing a compound annual growth rate (CAGR) of 8.2% between 2013 and 2017.
  • Market consumption volume increased with a CAGR of 1.9% between 2013 and 2017, to reach a total of 70.2% in 2017.
  • The US is the largest market in the world; it made up 33.5% of the global value in 2017. Other large markets include China, Japan, Germany, and India.
  • Reasons to buy
  • Save time carrying out entry-level research by identifying the size, growth, and leading players in the global generics market
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the global generics market
  • Leading company profiles reveal details of key generics market players' global operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the global generics market with five year forecasts by both value and volume
Table of Contents
Product Code: MLIG180057-01

Table of Contents

EXECUTIVE SUMMARY 2

  • Market value 2
  • Market value forecast 2
  • Market volume 2
  • Market volume forecast 2
  • Geography segmentation 2

Introduction 32

  • What is this report about? 32
  • Who is the target reader? 32
  • How to use this report 32
  • Definitions 32

Global Generics 33

  • Market Overview 33
  • Market Data 35
  • Market Segmentation 37
  • Market outlook 38
  • Five forces analysis 40

Generics in Asia-Pacific 46

  • Market Overview 46
  • Market Data 48
  • Market Segmentation 50
  • Market outlook 51
  • Five forces analysis 53

Generics in Europe 59

  • Market Overview 59
  • Market Data 61
  • Market Segmentation 63
  • Market outlook 64
  • Five forces analysis 66

Generics in France 72

  • Market Overview 72
  • Market Data 73
  • Market Segmentation 75
  • Market outlook 76
  • Five forces analysis 78
  • Macroeconomic indicators 84

Generics in Germany 86

  • Market Overview 86
  • Market Data 87
  • Market Segmentation 89
  • Market outlook 90
  • Five forces analysis 92
  • Macroeconomic indicators 98

Generics in Australia 100

  • Market Overview 100
  • Market Data 101
  • Market Segmentation 103
  • Market outlook 104
  • Five forces analysis 106
  • Macroeconomic indicators 112

Generics in Brazil 114

  • Market Overview 114
  • Market Data 115
  • Market Segmentation 117
  • Market outlook 118
  • Five forces analysis 120
  • Macroeconomic indicators 126

Generics in Canada 128

  • Market Overview 128
  • Market Data 129
  • Market Segmentation 131
  • Market outlook 132
  • Five forces analysis 134
  • Macroeconomic indicators 141

Generics in China 143

  • Market Overview 143
  • Market Data 144
  • Market Segmentation 146
  • Market outlook 147
  • Five forces analysis 149
  • Macroeconomic indicators 156

Generics in India 158

  • Market Overview 158
  • Market Data 159
  • Market Segmentation 161
  • Market outlook 162
  • Five forces analysis 164
  • Macroeconomic indicators 170

Generics in Indonesia 172

  • Market Overview 172
  • Market Data 173
  • Market Segmentation 175
  • Market outlook 176
  • Five forces analysis 178
  • Macroeconomic indicators 184

Generics in Italy 186

  • Market Overview 186
  • Market Data 187
  • Market Segmentation 189
  • Market outlook 190
  • Five forces analysis 192
  • Macroeconomic indicators 198

Generics in Japan 200

  • Market Overview 200
  • Market Data 201
  • Market Segmentation 203
  • Market outlook 204
  • Five forces analysis 206
  • Macroeconomic indicators 212

Generics in Mexico 214

  • Market Overview 214
  • Market Data 215
  • Market Segmentation 217
  • Market outlook 218
  • Five forces analysis 220
  • Macroeconomic indicators 226

Generics in The Netherlands 228

  • Market Overview 228
  • Market Data 229
  • Market Segmentation 231
  • Market outlook 232
  • Five forces analysis 234
  • Macroeconomic indicators 240

Generics in North America 242

  • Market Overview 242
  • Market Data 243
  • Market Segmentation 245
  • Market outlook 246
  • Five forces analysis 248

Generics in Russia 255

  • Market Overview 255
  • Market Data 256
  • Market Segmentation 258
  • Market outlook 259
  • Five forces analysis 261
  • Macroeconomic indicators 267

Generics in Scandinavia 269

  • Market Overview 269
  • Market Data 270
  • Market Segmentation 272
  • Market outlook 273
  • Five forces analysis 275

Generics in Singapore 281

  • Market Overview 281
  • Market Data 282
  • Market Segmentation 284
  • Market outlook 285
  • Five forces analysis 287
  • Macroeconomic indicators 293

Generics in South Africa 295

  • Market Overview 295
  • Market Data 296
  • Market Segmentation 298
  • Market outlook 299
  • Five forces analysis 301
  • Macroeconomic indicators 307

Generics in South Korea 309

  • Market Overview 309
  • Market Data 310
  • Market Segmentation 312
  • Market outlook 313
  • Five forces analysis 315
  • Macroeconomic indicators 321

Generics in Spain 323

  • Market Overview 323
  • Market Data 324
  • Market Segmentation 326
  • Market outlook 327
  • Five forces analysis 329
  • Macroeconomic indicators 335

Generics in Turkey 337

  • Market Overview 337
  • Market Data 338
  • Market Segmentation 340
  • Market outlook 341
  • Five forces analysis 343
  • Macroeconomic indicators 349

Generics in The United Kingdom 351

  • Market Overview 351
  • Market Data 352
  • Market Segmentation 354
  • Market outlook 355
  • Five forces analysis 357
  • Macroeconomic indicators 364

Generics in The United States 366

  • Market Overview 366
  • Market Data 367
  • Market Segmentation 369
  • Market outlook 370
  • Five forces analysis 372
  • Macroeconomic indicators 378

Company Profiles 380

  • Leading Companies 380

Appendix 457

  • Methodology 457
  • About MarketLine 458

List of Tables

  • Table 1: Global generics market value: $ billion, 2013-17
  • Table 2: Global generics market volume: % of total pharma, 2013-17
  • Table 3: Global generics market geography segmentation: $ billion, 2017
  • Table 4: Global generics market value forecast: $ billion, 2017-22
  • Table 5: Global generics market volume forecast: % of total pharma, 2017-22
  • Table 6: Asia-Pacific generics market value: $ billion, 2013-17
  • Table 7: Asia-Pacific generics market volume: % of total pharma, 2013-17
  • Table 8: Asia-Pacific generics market geography segmentation: $ billion, 2017
  • Table 9: Asia-Pacific generics market value forecast: $ billion, 2017-22
  • Table 10: Asia-Pacific generics market volume forecast: % of total pharma, 2017-22
  • Table 11: Europe generics market value: $ billion, 2013-17
  • Table 12: Europe generics market volume: % of total pharma, 2013-17
  • Table 13: Europe generics market geography segmentation: $ billion, 2017
  • Table 14: Europe generics market value forecast: $ billion, 2017-22
  • Table 15: Europe generics market volume forecast: % of total pharma, 2017-22
  • Table 16: France generics market value: $ million, 2013-17
  • Table 17: France generics market volume: % of total pharma, 2013-17
  • Table 18: France generics market geography segmentation: $ million, 2017
  • Table 19: France generics market value forecast: $ million, 2017-22
  • Table 20: France generics market volume forecast: % of total pharma, 2017-22
  • Table 21: France size of population (million), 2013-17
  • Table 22: France gdp (constant 2005 prices, $ billion), 2013-17
  • Table 23: France gdp (current prices, $ billion), 2013-17
  • Table 24: France inflation, 2013-17
  • Table 25: France consumer price index (absolute), 2013-17
  • Table 26: France exchange rate, 2013-17
  • Table 27: Germany generics market value: $ million, 2013-17
  • Table 28: Germany generics market volume: % of total pharma, 2013-17
  • Table 29: Germany generics market geography segmentation: $ million, 2017
  • Table 30: Germany generics market value forecast: $ million, 2017-22
  • Table 31: Germany generics market volume forecast: % of total pharma, 2017-22
  • Table 32: Germany size of population (million), 2013-17
  • Table 33: Germany gdp (constant 2005 prices, $ billion), 2013-17
  • Table 34: Germany gdp (current prices, $ billion), 2013-17
  • Table 35: Germany inflation, 2013-17
  • Table 36: Germany consumer price index (absolute), 2013-17
  • Table 37: Germany exchange rate, 2013-17
  • Table 38: Australia generics market value: $ million, 2013-17
  • Table 39: Australia generics market volume: % of total pharma, 2013-17
  • Table 40: Australia generics market geography segmentation: $ million, 2017
  • Table 41: Australia generics market value forecast: $ million, 2017-22
  • Table 42: Australia generics market volume forecast: % of total pharma, 2017-22
  • Table 43: Australia size of population (million), 2013-17
  • Table 44: Australia gdp (constant 2005 prices, $ billion), 2013-17
  • Table 45: Australia gdp (current prices, $ billion), 2013-17
  • Table 46: Australia inflation, 2013-17
  • Table 47: Australia consumer price index (absolute), 2013-17
  • Table 48: Australia exchange rate, 2013-17
  • Table 49: Brazil generics market value: $ million, 2013-17
  • Table 50: Brazil generics market volume: % of total pharma, 2013-17
  • Table 51: Brazil generics market geography segmentation: $ million, 2017
  • Table 52: Brazil generics market value forecast: $ million, 2017-22
  • Table 53: Brazil generics market volume forecast: % of total pharma, 2017-22
  • Table 54: Brazil size of population (million), 2013-17

List of Figures

  • Figure 1: Global generics market value: $ billion, 2013-17
  • Figure 2: Global generics market volume: % of total pharma, 2013-17
  • Figure 3: Global generics market geography segmentation: % share, by value, 2017
  • Figure 4: Global generics market value forecast: $ billion, 2017-22
  • Figure 5: Global generics market volume forecast: % of total pharma, 2017-22
  • Figure 6: Forces driving competition in the global generics market, 2017
  • Figure 7: Drivers of buyer power in the global generics market, 2017
  • Figure 8: Drivers of supplier power in the global generics market, 2017
  • Figure 9: Factors influencing the likelihood of new entrants in the global generics market, 2017
  • Figure 10: Factors influencing the threat of substitutes in the global generics market, 2017
  • Figure 11: Drivers of degree of rivalry in the global generics market, 2017
  • Figure 12: Asia-Pacific generics market value: $ billion, 2013-17
  • Figure 13: Asia-Pacific generics market volume: % of total pharma, 2013-17
  • Figure 14: Asia-Pacific generics market geography segmentation: % share, by value, 2017
  • Figure 15: Asia-Pacific generics market value forecast: $ billion, 2017-22
  • Figure 16: Asia-Pacific generics market volume forecast: % of total pharma, 2017-22
  • Figure 17: Forces driving competition in the generics market in Asia-Pacific, 2017
  • Figure 18: Drivers of buyer power in the generics market in Asia-Pacific, 2017
  • Figure 19: Drivers of supplier power in the generics market in Asia-Pacific, 2017
  • Figure 20: Factors influencing the likelihood of new entrants in the generics market in Asia-Pacific, 2017
  • Figure 21: Factors influencing the threat of substitutes in the generics market in Asia-Pacific, 2017
  • Figure 22: Drivers of degree of rivalry in the generics market in Asia-Pacific, 2017
  • Figure 23: Europe generics market value: $ billion, 2013-17
  • Figure 24: Europe generics market volume: % of total pharma, 2013-17
  • Figure 25: Europe generics market geography segmentation: % share, by value, 2017
  • Figure 26: Europe generics market value forecast: $ billion, 2017-22
  • Figure 27: Europe generics market volume forecast: % of total pharma, 2017-22
  • Figure 28: Forces driving competition in the generics market in Europe, 2017
  • Figure 29: Drivers of buyer power in the generics market in Europe, 2017
  • Figure 30: Drivers of supplier power in the generics market in Europe, 2017
  • Figure 31: Factors influencing the likelihood of new entrants in the generics market in Europe, 2017
  • Figure 32: Factors influencing the threat of substitutes in the generics market in Europe, 2017
  • Figure 33: Drivers of degree of rivalry in the generics market in Europe, 2017
  • Figure 34: France generics market value: $ million, 2013-17
  • Figure 35: France generics market volume: % of total pharma, 2013-17
  • Figure 36: France generics market geography segmentation: % share, by value, 2017
  • Figure 37: France generics market value forecast: $ million, 2017-22
  • Figure 38: France generics market volume forecast: % of total pharma, 2017-22
  • Figure 39: Forces driving competition in the generics market in France, 2017
  • Figure 40: Drivers of buyer power in the generics market in France, 2017
  • Figure 41: Drivers of supplier power in the generics market in France, 2017
  • Figure 42: Factors influencing the likelihood of new entrants in the generics market in France, 2017
  • Figure 43: Factors influencing the threat of substitutes in the generics market in France, 2017
  • Figure 44: Drivers of degree of rivalry in the generics market in France, 2017
  • Figure 45: Germany generics market value: $ million, 2013-17
  • Figure 46: Germany generics market volume: % of total pharma, 2013-17
  • Figure 47: Germany generics market geography segmentation: % share, by value, 2017
  • Figure 48: Germany generics market value forecast: $ million, 2017-22
  • Figure 49: Germany generics market volume forecast: % of total pharma, 2017-22
  • Figure 50: Forces driving competition in the generics market in Germany, 2017
  • Figure 51: Drivers of buyer power in the generics market in Germany, 2017
  • Figure 52: Drivers of supplier power in the generics market in Germany, 2017
  • Figure 53: Factors influencing the likelihood of new entrants in the generics market in Germany, 2017
  • Figure 54: Factors influencing the threat of substitutes in the generics market in Germany, 2017
  • Figure 55: Drivers of degree of rivalry in the generics market in Germany, 2017
  • Figure 56: Australia generics market value: $ million, 2013-17
  • Figure 57: Australia generics market volume: % of total pharma, 2013-17
  • Figure 58: Australia generics market geography segmentation: % share, by value, 2017
Back to Top